Neil Tween

Trustee

Neil Tween is Chief Financial Officer of Owlstone Medical Limited, a Cambridge-based company whose mission is to save 100,000 lives and become the global leader in breath diagnosis for early detection and precision medicine.

Neil is a Fellow of the Institute of Chartered Accountants of England and Wales (ICAEW), and has previously held senior finance positions in fast-growing UK-based companies, most recently as VP, Financial Controller at GW Pharmaceuticals, a US-listed biopharmaceutical company which launched medicines in the United States, Europe and the UK to treat patients with rare types of epilepsy that begin in childhood and can continue into adulthood.

Male facing the camera wearing a blue and white shirt